|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0011847,
umls-concept:C0020507,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0038257,
umls-concept:C0220825,
umls-concept:C0288672,
umls-concept:C0332293,
umls-concept:C0936012,
umls-concept:C1274040,
umls-concept:C1539218
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2004-2-24
|
|
pubmed:abstractText |
In diabetic patients in the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) trial, abciximab reduced target vessel revascularization by approximately 50% compared with placebo. Whether this is a result of a lower restenosis rate caused by inhibition of intimal hyperplasia remains to be defined.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:AbizaidAlexandreA,
pubmed-author:AbizaidAndreaA,
pubmed-author:CentemeroMarinellaM,
pubmed-author:ChavesAurea JAJ,
pubmed-author:CostaMarco AMA,
pubmed-author:FeresFaustoF,
pubmed-author:MaldonadoGaloG,
pubmed-author:MattosLuiz ALA,
pubmed-author:MintzGary SGS,
pubmed-author:PaesAngelaA,
pubmed-author:PintoIbraimI,
pubmed-author:SeixasAnaA,
pubmed-author:SousaAmanda G M RAG,
pubmed-author:SousaJ EduardoJE,
pubmed-author:StaicoRodolfoR,
pubmed-author:TanajuraLuiz FLF
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
24
|
|
pubmed:volume |
109
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
861-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14757690-Aged,
pubmed-meshheading:14757690-Antibodies, Monoclonal,
pubmed-meshheading:14757690-Brazil,
pubmed-meshheading:14757690-Cardiovascular Diseases,
pubmed-meshheading:14757690-Coronary Angiography,
pubmed-meshheading:14757690-Coronary Restenosis,
pubmed-meshheading:14757690-Coronary Stenosis,
pubmed-meshheading:14757690-Diabetes Mellitus, Type 2,
pubmed-meshheading:14757690-Disease-Free Survival,
pubmed-meshheading:14757690-Female,
pubmed-meshheading:14757690-Humans,
pubmed-meshheading:14757690-Hyperplasia,
pubmed-meshheading:14757690-Imaging, Three-Dimensional,
pubmed-meshheading:14757690-Immunoglobulin Fab Fragments,
pubmed-meshheading:14757690-Incidence,
pubmed-meshheading:14757690-Life Tables,
pubmed-meshheading:14757690-Male,
pubmed-meshheading:14757690-Middle Aged,
pubmed-meshheading:14757690-Platelet Aggregation Inhibitors,
pubmed-meshheading:14757690-Postoperative Complications,
pubmed-meshheading:14757690-Prospective Studies,
pubmed-meshheading:14757690-Single-Blind Method,
pubmed-meshheading:14757690-Stents,
pubmed-meshheading:14757690-Surgical Procedures, Elective,
pubmed-meshheading:14757690-Treatment Failure,
pubmed-meshheading:14757690-Tunica Intima,
pubmed-meshheading:14757690-Ultrasonography, Interventional
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial.
|
|
pubmed:affiliation |
Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
